CME
CME Group Inc.
—
246.38 $
-6.1600 (%-2.44)
Previous Close: 252.54
Day Low₺245.61
Day High₺257.93
CME: CME Group Inc. Financials
CME Income Statement
Total revenue
Net income
Gross margin TTM
86.09%
Operating margin TTM
64.86%
Net profit margin TTM
62.02%
Return on investment TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 6,520,600,000 | 6,130,100,000 | 5,578,900,000 | 5,019,400,000 |
| Operating income | 4,229,500,000 | 3,931,500,000 | 3,435,700,000 | 3,015,900,000 |
| Net income | 4,044,400,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 6,520,600,000 | 6,130,100,000 | 5,578,900,000 | 5,019,400,000 |
| Cost of revenue | 907,000,000 | 850,300,000 | 828,600,000 | 753,100,000 |
| Gross profit | 5,613,600,000 | 5,279,800,000 | 4,750,300,000 | 4,266,300,000 |
| Research and development expenses | 0 | 0 | 0 | 0 |
| General and administrative expenses | 150,500,000 | 132,700,000 | 144,400,000 | 137,400,000 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 150,500,000 | 132,700,000 | 144,400,000 | 137,400,000 |
| Other expenses | 1,233,600,000 | 1,215,600,000 | 1,170,200,000 | 1,113,000,000 |
| Operating expenses | 1,384,100,000 | 1,348,300,000 | 1,314,600,000 | 1,250,400,000 |
| Cost and expenses | 2,291,100,000 | 2,198,600,000 | 2,143,200,000 | 2,003,500,000 |
| Net interest income | -129,700,000 | -160,900,000 | -159,400,000 | -162,700,000 |
| Interest income | 0 | 0 | 0 | 0 |
| Interest expense | 129,700,000 | 160,900,000 | 159,400,000 | 162,700,000 |
| Depreciation and amortization | 275,000,000 | 336,800,000 | 352,600,000 | 362,600,000 |
| EBITDA | 5,720,300,000 | 5,039,100,000 | 4,665,600,000 | 4,015,600,000 |
| EBIT | 5,445,300,000 | 4,702,300,000 | 4,313,000,000 | 3,653,000,000 |
| Non-operating income (excl. interest) | -1,215,700,000 | -770,800,000 | -877,300,000 | -637,100,000 |
| Operating income | 4,229,500,000 | 3,931,500,000 | 3,435,700,000 | 3,015,900,000 |
| Total other income/expenses (net) | 1,101,000,000 | 609,900,000 | 717,900,000 | 474,400,000 |
| Income before tax | 5,330,500,000 | 4,541,400,000 | 4,153,600,000 | 3,490,300,000 |
| Income tax expense | 1,273,200,000 | 1,015,600,000 | 927,400,000 | 799,300,000 |
| Net income from continuing operations | 4,057,300,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 4,044,400,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
| Net income deductions | -5,700,000 | 0 | 0 | 0 |
| Bottom line net income | 4,021,000,000 | 3,481,500,000 | 3,185,600,000 | 2,657,200,000 |
| EPS | 11 | 10 | 9 | 7 |
| Diluted EPS | 11 | 10 | 9 | 7 |
| Weighted average shares outstanding | 359,633,000 | 359,389,000 | 359,023,000 | 358,713,000 |
| Weighted average diluted shares outstanding | 360,233,000 | 359,944,000 | 359,500,000 | 359,181,000 |